Synergy Pharmaceuticals Inc (SGYP)

5.30
NASDAQ : Health Care
Prev Close 5.11
Day Low/High 5.11 / 5.35
52 Wk Low/High 2.50 / 6.35
Avg Volume 2.88M
Exchange NASDAQ
Shares Outstanding 179.95M
Market Cap 919.56M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Synergy Pharmaceuticals To Present At Jefferies 2016 London Healthcare Conference

Synergy Pharmaceuticals To Present At Jefferies 2016 London Healthcare Conference

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the company will present a corporate update at the Jefferies London Healthcare Conference on Wednesday, November 16, 2016 at 8:00 a.

Synergy Pharmaceuticals Reports Third Quarter 2016 Financial Results And Business Update

Synergy Pharmaceuticals Reports Third Quarter 2016 Financial Results And Business Update

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and business update for...

Synergy Pharmaceuticals Becomes Oversold (SGYP)

Synergy Pharmaceuticals Becomes Oversold (SGYP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Short Interest Makes 10.6% Move For SGYP

Short Interest Makes 10.6% Move For SGYP

The most recent short interest data has been released for the 10/14/2016 settlement date, which shows a 2,623,458 share increase in total short interest for Synergy Pharmaceuticals Inc , to 27,315,643, an increase of 10.62% since 09/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of SGYP December 16th Options Trading

First Week of SGYP December 16th Options Trading

Investors in Synergy Pharmaceuticals Inc saw new options become available this week, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP options chain for the new December 16th contracts and identified one put and one call contract of particular interest.

Synergy Pharmaceuticals Presents Long-Term Data For Plecanatide In Chronic Idiopathic Constipation At The American College Of Gastroenterology (ACG) Annual Scientific Meeting

Synergy Pharmaceuticals Presents Long-Term Data For Plecanatide In Chronic Idiopathic Constipation At The American College Of Gastroenterology (ACG) Annual Scientific Meeting

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today presented new long-term safety data of plecanatide, its investigational, orally-administered compound currently being evaluated by the U.

Lack of Catalysts Keeps Analysts Away From Pfizer

Lack of Catalysts Keeps Analysts Away From Pfizer

Pfizer may not be the best investment in coming months, as doubts surface about the company's near-term prospects in the absence of M&A.

Synergy Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Synergy Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that the independent Compensation Committee of the Board of Directors of Synergy approved the grant of an inducement stock option to purchase 50,000 shares of...

Synergy Pharmaceuticals Announces New Plecanatide Data Presentations At Upcoming Scientific Meeting And Provides Update On IBS-C Program

Synergy Pharmaceuticals Announces New Plecanatide Data Presentations At Upcoming Scientific Meeting And Provides Update On IBS-C Program

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that the company will present new data on plecanatide, an investigational compound for the treatment of chronic idiopathic constipation (CIC) and irritable bowel...

Synergy Pharmaceuticals To Present At OctoberINVESTfest 2016

Synergy Pharmaceuticals To Present At OctoberINVESTfest 2016

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the company will present at the OctoberINVESTfest Conference on Wednesday, September 28, 2016 at 11:30 a.

First Week of SGYP November 18th Options Trading

First Week of SGYP November 18th Options Trading

Investors in Synergy Pharmaceuticals Inc saw new options become available this week, for the November 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP options chain for the new November 18th contracts and identified one put and one call contract of particular interest.

Bought Aerie Earlier? Congratulations

Bought Aerie Earlier? Congratulations

An update on some recent small biotech recommendations.

7 Stocks Under $10 Making Big Moves Higher

7 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Here's a Reason Why Synergy Pharma (SGYP) Stock Is Rallying Today

Here's a Reason Why Synergy Pharma (SGYP) Stock Is Rallying Today

Synergy Pharma (SGYP) stock is rising on Wednesday as Citi said the company could be a potential target for Takeda Pharmaceutical (TKPYY).

Interesting SGYP Put And Call Options For January 2019

Interesting SGYP Put And Call Options For January 2019

Investors in Synergy Pharmaceuticals Inc saw new options begin trading today, for the January 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 858 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Synergy Pharmaceuticals To Present At 18th Annual Rodman & Renshaw Global Investment Conference

Synergy Pharmaceuticals To Present At 18th Annual Rodman & Renshaw Global Investment Conference

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced Marino Garcia, the company's EVP and Chief Strategy Officer, will present a corporate update at the Rodman & Renshaw Conference on Monday, September 12, 2016...

'Mad Money' Lightning Round: JetBlue Has No Upside

'Mad Money' Lightning Round: JetBlue Has No Upside

Cramer likes XPO Logistics but wants no part of GNC Holdings.

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Earnings season is far from over, Cramer says, and the Fed chief gives a major speech Friday.

SGYP April 2017 Options Begin Trading

SGYP April 2017 Options Begin Trading

Investors in Synergy Pharmaceuticals Inc saw new options become available today, for the April 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Synergy Pharmaceuticals Reports Second Quarter 2016 Financial Results And Business Update

Synergy Pharmaceuticals Reports Second Quarter 2016 Financial Results And Business Update

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and business update for...

Bullish Two Hundred Day Moving Average Cross - SGYP

Bullish Two Hundred Day Moving Average Cross - SGYP

In trading on Thursday, shares of Synergy Pharmaceuticals Inc crossed above their 200 day moving average of $4.22, changing hands as high as $4.34 per share. Synergy Pharmaceuticals Inc shares are currently trading up about 0.2% on the day.

Synergy Pharmaceuticals To Present At Canaccord Genuity 36th Annual Growth Conference

Synergy Pharmaceuticals To Present At Canaccord Genuity 36th Annual Growth Conference

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced Marino Garcia, the company's EVP and Chief Strategy Officer, will present a corporate update at the Canaccord Genuity 36 th Annual Growth Conference on Thursday,...

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

Biogen Should Either a Buyer or a Seller Be

Biogen Should Either a Buyer or a Seller Be

The company sans CEO Scangos needs to do some type of deal in the coming months.

Synergy Pharma Offers Lots of Synergies

Synergy Pharma Offers Lots of Synergies

I expect Allergan or another player to bid for SGYP soon.

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal

Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.